137 related articles for article (PubMed ID: 31273578)
1. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.
Roci E; Cakani B; Brace G; Bushati T; Rroji A; Petrela M; Kaloshi G
Med Arch; 2014; 68(2):140-3. PubMed ID: 24937942
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin chemotherapy in patients with recurrent high-grade glioma.
Murray LJ; Bridgewater CH; Levy D
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):55-61. PubMed ID: 20952169
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
[TBL] [Abstract][Full Text] [Related]
6. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.
Warnick RE; Prados MD; Mack EE; Chandler KL; Doz F; Rabbitt JE; Malec MK
J Neurooncol; 1994; 19(1):69-74. PubMed ID: 7815106
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
Yao H; Liu J; Zhang C; Shao Y; Li X; Feng M; Wang X; Gan W; Zhou Y; Huang Y
J Clin Neurosci; 2021 Aug; 90():82-88. PubMed ID: 34275586
[TBL] [Abstract][Full Text] [Related]
10. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
11. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of carboplatin in children with progressive low-grade gliomas.
Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Poisson M; Péréon Y; Chiras J; Delattre JY
J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
[TBL] [Abstract][Full Text] [Related]
14. Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.
Nagpal S; Recht CK; Bertrand S; Thomas RP; Ajlan A; Pena J; Gershon M; Coffey G; Kunz PL; Li G; Recht LD
J Neurooncol; 2015 Jun; 123(2):277-82. PubMed ID: 25935109
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
Tonder M; Weller M; Eisele G; Roth P
Chemotherapy; 2014; 60(5-6):375-8. PubMed ID: 26496463
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CS; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; ; Rosenthal MA
Neuro Oncol; 2015 Nov; 17(11):1504-13. PubMed ID: 26130744
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M
J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050
[TBL] [Abstract][Full Text] [Related]
18. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
[TBL] [Abstract][Full Text] [Related]
20. Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.
Wahl M; Chang SM; Phillips JJ; Molinaro AM; Costello JF; Mazor T; Alexandrescu S; Lupo JM; Nelson SJ; Berger M; Prados M; Taylor JW; Butowski N; Clarke JL; Haas-Kogan D
Cancer; 2017 Dec; 123(23):4631-4639. PubMed ID: 28759109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]